Журнал кардиореспираторных исследований 2025. №2/3
Maqola mavzusi
MODIFICATION OF ANTI-GLYCEROUS THERAPY AS A FACTOR IN IMPROVING THE QUALITY OF LIFE IN ELDERLY PATIENTS WITH TYPE 2 DIABETES (59-62)
Mualliflar
Normatov Murodjon Bo’riboyevich, Khaydarov Sanjar Nizamitdinovich
Muassasa
Samarkand State Medical University
Annotatsiya
Relevance. Type 2 diabetes mellitus (T2DM) is widespread among elderly people and causes serious macro- and microvascular complications. A characteristic feature of T2DM in elderly patients is an increased risk of developing geriatric syndromes and hypoglycemic conditions, which leads to a significant decrease in their quality of life. The aim of our study was to examine the quality of life of elderly patients with type 2 diabetes mellitus and the impact of glucose-lowering therapy on it. Materials and methods. We conducted a prospective randomized study involving 2 groups of elderly women. The first group consisted of 40 patients with T2DM (mean age 68.25 ± 4.12 years) receiving traditional glucose-lowering therapy. The second group consisted of 40 patients with T2DM (mean age 68.35 ± 3.89 years) treated with our developed method: diet #9, intravenous gliclazide, metformin, sublet, cholecalciferol drops (loading dose for a month, then maintenance dose), and physical activity. Elderly patients with T2DM experience a decrease in health-related quality of life. Conclusions: Modification of glucose-lowering therapy by adding cholecalciferol and metformin to the usual treatment regimen contributed to improving the quality of life in this category of patients. This treatment method is safe, has a low risk of hypoglycemia, and helps reduce patients' body weight.
Kalit so'zlar
type 2 diabetes mellitus, quality of life, hypoglycemia, cholecalciferol, metformin
Adabiyotlar
1. Yarmukhamedova, S. K., Alisherovna, K. M., Tashtemirovna, E. M. M., & Nizamitdinovich, K. S. (2023). The Effectiveness of Trimetazidine in Arrhythmias. Miasto Przyszłości, 33, 215-221. 2. Yarmukhamedova, S. K., Normatov, M. B., & Amirova, S. A. (2021). Modification of structural and functional indicators of the heart in diabetes mellitus patients with diastolic heart failure. Journal of Advanced Medical and Dental Sciences Research, 9(5), 1-4. 3. Nizamitdinovich, K. S., Khabibovna, Y. S., Alisherovna, K. M., & Tashtemirovna, E. M. M. (2023). Spinal Injury for Rheumatoid Arthritis. Miasto Przyszłości, 40, 426-432. 4. Tashtemirovna, E. M. M., Khabibovna, Y. S., Alisherovna, K. M., & Erkinovna, K. Z. (2023). Angiopathy in Rheumatoid Arthritis. Miasto Przyszłości, 40, 418-425. 5. Khabibovna, Y. S., Alisherovna, K. M., Erkinovna, K. Z., & Djamshedovna, K. D. (2023). Gender Characteristics of the Course of Rheumatoid Arthritis. Miasto Przyszłości, 40, 438-442. 6. Khabibovna, Y. S., & Buribaevich, N. M. (2020). Study Of Parameters Of Central Hemodynamics In Patients With Chronic Glomerulonephritis. Достижения науки и образования, (13 (67)), 57-59. 7. Habibovna, Y. S., & Bo’Riboyevich, N. M. (2020). Surunkali Glomerulonefrit Bilan Og ‘Rigan Bemorlarda Arterial Qon Bosimining Sutkalik Monitoring Ko ‘Rsatkichlarini Baxolash. Journal of cardiorespiratory research, 1(1), 103-108. 8. Khabibovna, Y. S., & Abdukodirovna, A. S. (2021). Changes in the diastolic function of the right ventricle in arterial hypertension. 9. Yarmuxamedova, S. X., & Normatov, M. B. R. (2021). SURUNKALI GLOMERULONEFRIT BILAN OG'RIGAN BEMORLARDA MARKAZIY GEMODINAMIKA KO'RSATKICHLARINI BAHOLASH. Scientific progress, 2(2), 696-699. 10. Yarmuxamedova, S. X., & Normatov, M. B. R. (2021). SURUNKALI GLOMERULONEFRIT BILAN KASALLANGAN BEMORLARDA SUTKALIK QON BOSIMINING XARAKTERISTIKASI. Scientific progress, 2(2), 706-710.